Literature DB >> 29341844

Empiric Antibiotics for Sepsis.

Sara A Buckman1, Isaiah R Turnbull1, John E Mazuski1.   

Abstract

BACKGROUND: Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. Early recognition and treatment are the cornerstones of management.
METHODS: Review of the English-language literature.
RESULTS: For both sepsis and septic shock "antimicrobials [should be] be initiated as soon as possible and within one hour" (Surviving Sepsis Campaign). The risk of progression from severe sepsis to septic shock increases 8% for each hour before antibiotics are started. Selection of antimicrobial agents is based on a combination of patient factors, predicted infecting organism(s), and local microbial resistance patterns. The initial drugs should have activity against typical gram-positive and gram-negative causative micro-organisms. Anaerobic coverage should be provided for intra-abdominal infections or others where anaerobes are significant pathogens. Empiric antifungal or antiviral therapy may be warranted. For patients with healthcare-associated infections, resistant micro-organisms will further complicate the choice of empiric antimicrobials. Recommendations are given for specific infections.
CONCLUSION: Early administration of broad-spectrum antimicrobial drugs is one of the most important, if not the most important, treatment for patients with sepsis or septic shock. Drugs should be initiated as soon as possible, and the choice of should take into account patient factors, common local pathogens, hospital antibiograms and resistance patterns, and the suspected source of infection. Antimicrobial agent therapy should be de-escalated as soon as possible.

Entities:  

Keywords:  antimicrobial de-escalation; antimicrobials; sepsis

Mesh:

Substances:

Year:  2018        PMID: 29341844     DOI: 10.1089/sur.2017.282

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  11 in total

1.  Discrimination of Methicillin-resistant Staphylococcus aureus by MALDI-TOF Mass Spectrometry with Machine Learning Techniques in Patients with Staphylococcus aureus Bacteremia.

Authors:  Po-Hsin Kong; Cheng-Hsiung Chiang; Ting-Chia Lin; Shu-Chen Kuo; Chien-Feng Li; Chao A Hsiung; Yow-Ling Shiue; Hung-Yi Chiou; Li-Ching Wu; Hsiao-Hui Tsou
Journal:  Pathogens       Date:  2022-05-16

2.  Efficacy of Oxymatrine Plus Antiviral in the Treatment of Sepsis and Its Effect on the Levels of Endotoxin and Inflammatory Factors.

Authors:  Jinglin Zhao; Qi Wei; Shengchao Guo; Hao Wang; Chao Zhao; Caihong Hu; Cuicui Liu; Qingchun Dai; Rui Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-24       Impact factor: 2.650

3.  Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Authors:  Robert Strengen Bigseth; Håkon Sandholdt; Andreas Petersen; Christian Østergaard; Thomas Benfield; Louise Thorlacius-Ussing
Journal:  Microbiol Spectr       Date:  2022-04-19

4.  Effect of delayed entry on performance of the BACT/ALERT FAN PLUS bottles in the BACT/ALERT VIRTUO blood culture system.

Authors:  Mary Adamik; Anne Hutchins; Jasmin Mangilit; Betsy Katzin; Heather Totty; Parampal Deol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-09       Impact factor: 3.267

5.  What Do We Know about Early Management of Sepsis and Septic Shock in Polish Hospitals? A Questionnaire Study.

Authors:  Łukasz J Krzych; Agnieszka Wiórek; Paweł Zatorski; Karol Gruca; Karina Stefańska-Wronka; Janusz Trzebicki
Journal:  Healthcare (Basel)       Date:  2021-02-01

6.  Novel Treatments Targeting the Dysregulated Cell Signaling Pathway during Sepsis.

Authors:  Justin H Franco; Xiaohuan Chen; Zhixing K Pan
Journal:  J Cell Signal       Date:  2021-12

7.  Tuberculosis-Associated Septic Shock: A Case Series.

Authors:  Veerendra Arya; Amarendra K Shukla; Brahma Prakash; Jitendra K Bhargava; Akriti Gupta; Brij B Patel; Pawan Tiwari
Journal:  Cureus       Date:  2022-03-17

8.  "Appropriate" Versus "Inappropriate" Antibiotic Administration, "Prior To" Versus "After" the Diagnosis of Septic Shock. Impact on Patients with Sepsis Admitted to a Saudi Intensive Care Unit.

Authors:  Haifa M Algethamy; Ayman Morish; Mohammad S Numan; Abdullah F Alotaibi
Journal:  Mater Sociomed       Date:  2020-03

9.  Mortality related to drug-resistant organisms in surgical sepsis-3: an 8-year time trend study using sequential organ failure assessment scores.

Authors:  Junichi Yoshida; Tetsuro Tamura; Kazuhiro Otani; Masaaki Inoue; Eiji Miyatake; Toshiyuki Ishimitsu; Chihiro Nakahara; Masao Tanaka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-09-21       Impact factor: 3.267

Review 10.  The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review.

Authors:  Alessandro Lazzaro; Gabriella De Girolamo; Valeria Filippi; Giuseppe Pietro Innocenti; Letizia Santinelli; Giancarlo Ceccarelli; Enrico Maria Trecarichi; Carlo Torti; Claudio Maria Mastroianni; Gabriella d'Ettorre; Alessandro Russo
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.